Enanta Pharmaceuticals
ENTA
ENTA
132 hedge funds and large institutions have $225M invested in Enanta Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 45 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 133 → 132 (-1)
47% less call options, than puts
Call options by funds: $9K | Put options by funds: $17K
49% less capital invested
Capital invested by funds: $438M → $225M (-$213M)
Holders
132
Holding in Top 10
1
Calls
$9K
Puts
$17K
Top Buyers
| 1 | +$8.82M | |
| 2 | +$6.07M | |
| 3 | +$5M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.45M |
| 5 |
Morgan Stanley
New York
|
+$2.87M |
Top Sellers
| 1 | -$19.6M | |
| 2 | -$11.9M | |
| 3 | -$3.22M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.78M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$2.47M |